Lifestar Pharma began in 2005 as the first separate financial entity of Mankind with a base of Rs. 90 million. By 2016-17, Lifestar achieved remarkable success with a turnover of Rs. 7100 million. Lifestar Pharma aims to achieve a turnover of Rs. 10000 million by 2018-19.
Lifestar Pharma has always aimed at providing world-class products in public domain. Major therapeutic focus areas of Lifestar are Gynecology, Dermatology, Ophthalmology & Pediatrics. Some of Lifestar Pharma’s brands are Gudcef, Asthakind, Argipreg, Terbinaforce, Ketostar, Hairbless, Ovabless, Biopreg-F, Urikind KM Sachet and Entromax.
Lifestar Pharma continues to be a low-cost warrior. All products are affordable as compared to other competitor brands. Lifestar carved a niche for itself by entering rural markets and slashing drug prices, making it one of the fastest growing pharmaceutical companies within a decade. Economical products include Letrohope, Terbinaforce TABLETS, Asthakind, Ketostar etc.
The product spectrum encompasses brands which have been launched in India for the first time and is one of the main drivers of growth for Lifestar Pharma.
Lifestar Pharma’s strategic vision of serving life with products of outstanding quality at affordable prices has transformed the pharmaceutical industry towards new ways of thinking.